(29) reported that exosome component 1 (EXOSC1) sensitizes RCC cells to PARPis, suggesting that PARP inhibition may be an effective strategy for the treatment of Kidney renal clear cell carcinoma (KIRC) patients with high EXOSC1. The gene discussed is EXOSC1; the disease is renal cell carcinoma.